Buccal Bone Resorption in Immediate SLActive Implant Placement Thin vs. Thick Buccal Bone

January 22, 2024 updated by: Hani Elnahass, Cairo University

Evaluation of the Buccal Bone Resorption in Immediate SLActive Implant Placement in Thin vs. Thick Buccal Bone Plates: RCT

The utilization of SLActive implants which allow more rapid osseointgeration with 3 to 4 weeks. will be placed in thin buccal bone as immediate implants to determine the resorption compared to thick buccal bone

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

With the increased demand for aesthetics and the expectation of immediate tooth replacement, improving the treatment options in case with hopeless teeth in the esthetic zone by immediate implants is a need by both practitioners and patients.

Current guidelines, today, restricting such treatment to only thick (+ or = 1mm) buccal bone plates. However, the literature shows that less than 10% of the community have such criteria, making it a high risk but needed procedure.

Soft tissue and bone remodelling after extraction is an inescapable fact. Immediate implant placement cannot prevent soft tissue and bone remodeling around implants (Araújo et al. 2005, Chen et al. 2009), but implant surface treatment and modifications might enhance the maintainability of the supporting structures around the dental implant due to its faster integration, better stimulating the vascular components at the site. This could be tested by the crestal and buccal bone changes, pink esthetic score and ostell readings.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Faculty of Oral and Dental Medicine Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Single bounded irrestorable tooth in the esthetic zone that needs to be extracted.
  2. Healthy systemic condition.
  3. Type I socket with a minimum of 1mm of buccal bone thickness prior to extraction. (Morton et al., 2014)
  4. Sufficient bone apical to the socket for implant primary stability. (Morton et al., 2014)
  5. Good oral hygiene.
  6. Patient accepts a minimum of three-year follow-up period (cooperative patients).

Exclusion Criteria:

  1. Signs of acute infection related to the area of interest.
  2. Patients with parafunctional habits (Lobbezoo et al. 2006 and Roelhing et al. 2016).
  3. Smokers (Lambert et al. 2000).
  4. Pregnant females.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: thin buccal bone
Minimally traumatic tooth extraction, immediate implant placement and hard tissue grafting. loading after 3 months.
Active Comparator: thick buccal bone
Minimally traumatic tooth extraction, immediate implant placement and hard tissue grafting. loading after 3 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bucccal bone changes
Time Frame: 12 months post loading
standardized Cone beam computed Tomography The radiograph will be taken preoperatively and 12 month after. The pre and post operative cone beams will be compared to each other observing any changes of the buccal bone at 2 , 4 and 6 mm from the crest, the measurements will be in mm
12 months post loading

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant stability
Time Frame: 3 months
Ostell readings in isq (range from 55 till over 70) bleow 55 low stability over 55 till 65 moderate stability above 70 good stability
3 months
Crestal bone changes
Time Frame: 12 months post loading
Periapical radiograph the measurements will be taken from the platform of the implants. 3 readings will be taken one at the paltform one above and one below according to pattern and form of the resorption.
12 months post loading
Soft tissue thickness
Time Frame: 3 months
Periodontal probe
3 months
Post operative pain and swelling
Time Frame: 1 week
Blinded assessment ( numerical score)
1 week
Buccal bone thickness
Time Frame: 3 months
Cone Beam Computed Topography
3 months
Postsurgical satisfaction
Time Frame: 1 week
Questionnaire
1 week
Pink aesthetic score
Time Frame: 12 months post loading
Pink esthetic score Scale 0 being the lowest and 14 highest attainable
12 months post loading

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2017

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

June 1, 2022

Study Registration Dates

First Submitted

January 25, 2021

First Submitted That Met QC Criteria

January 28, 2021

First Posted (Actual)

February 1, 2021

Study Record Updates

Last Update Posted (Estimated)

January 23, 2024

Last Update Submitted That Met QC Criteria

January 22, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 333

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implant

Clinical Trials on immediate implant placement

3
Subscribe